AAM Urges Biden-Harris Administration To Increase Biosimilar Reimbursement

As IQVIA Study Predicts $69bn-$140bn In US Healthcare Savings Due To Biosimilars

 
• By Akriti Seth
  
Biden Harris
AAM asks policymakers to act on biosimilar reimbursement • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products